Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated Donor Stem Cell Transplant for Hematological Malignancies
NCT00281879Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Feb 2006
- Primary completion
- Feb 2008
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by OHSU Knight Cancer Institute. Started Feb 2006; status: terminated.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)chronic myelogenous leukemia (CML)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00281879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281879.